Return to Trial Database

HCRN-GU21-517

A Phase 2 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer (CANOPY)

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Publications

A phase 2 study of cabozantinib and nivolumab in metastatic castration-resistant prostate cancer (CANOPY)

Trial Locations

All sites in which the trial HCRN-GU21-517 being conducted in.

Moores Cancer Center at UC San Diego Health

The University of Chicago Medicine Comprehensive Cancer Center

University of Wisconsin Carbone Cancer Center

UT Southwestern Harold C. Simmons Comprehensive Cancer Center